These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 891373)

  • 1. [Stimulation of renin-angiotensin-aldosterone system as screening test for hypertension].
    Kley R; Lommel H
    Dtsch Med Wochenschr; 1977 Jul; 102(28):1037-8. PubMed ID: 891373
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic ability of the renin-angiotensin-aldosterone-system (R.A.A.-system) stimulation as a screening test in hypertension].
    Schnurr E; Küppers H; Grabensee B
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():207. PubMed ID: 613574
    [No Abstract]   [Full Text] [Related]  

  • 3. [The value of stimulation of the renin-angiotensin-aldosterone system as a screening test for hypertension (author's transl)].
    Küppers H; Schnurr E; Grabensee B
    Dtsch Med Wochenschr; 1977 May; 102(18):693-6. PubMed ID: 880879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reliability and diagnostic use of the furosemide test in the study of the renin-angiotensin-aldosterone system].
    Cugini P; Scavo D
    Boll Soc Ital Cardiol; 1978; 23(8):1267-83. PubMed ID: 398707
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of beta blockade on the renin-angiotensin-aldosterone system [proceedings].
    Lijnen PJ; Amery AK; Fagard RH
    Arch Int Physiol Biochim; 1979 Feb; 87(1):191-3. PubMed ID: 92268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renin-angiotensin-aldosterone system and electrolytes metabolism on furosemide stimulation test (author's transl)].
    Suzuki T; Ito T
    Nihon Jinzo Gakkai Shi; 1978 Jul; 20(7):759-69. PubMed ID: 722978
    [No Abstract]   [Full Text] [Related]  

  • 7. [The renin-angiotensin-aldosterone system in essential arterial hypertension].
    Ruilope L; Alcazar JM; García Robles R; Gutiérrez Millet V; Jarillo MD; Torres J; Morales JM; Rodicio JL
    Rev Clin Esp; 1977 Sep; 146(5):233-7. PubMed ID: 928859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
    Stumpe KO; Kolloch R; Gramann W; Vetter H; Krück F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1325-8. PubMed ID: 1029991
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renin, angiotensin and aldosterone in the diagnosis of hypertension].
    Pasternack A; Fyhrqvist F
    Duodecim; 1975; 91(7):461-73. PubMed ID: 1140119
    [No Abstract]   [Full Text] [Related]  

  • 10. [New findings on the behavior of the renin-angiotensin-aldosterone system in obesity].
    Cugini P; Serdoz R; Manconi R; Mancini A; Meucci T
    Boll Soc Ital Biol Sper; 1978 Mar; 54(6):529-32. PubMed ID: 743469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation of plasma renin activity and aldosterone excretion rate in angiotensin II-test and its diagnostic value in arterial hypertension patients].
    Hartrodt W; Brosowski KH; Gohlke HR; Kreher C
    Dtsch Gesundheitsw; 1971 Aug; 26(32):1500-7. PubMed ID: 4329817
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide in normal and low renin essential hypertension.
    Sergev O; Rácz K; Varga I; Kiss R; Fütö L; Gláz E
    Kidney Int Suppl; 1990 Nov; 30():S107-8. PubMed ID: 2147964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
    Armanini D; Guido R; Fallo F; Opocher G; Mantero F
    Clin Ter; 1976 Oct; 79(1):41-62. PubMed ID: 1017163
    [No Abstract]   [Full Text] [Related]  

  • 16. [Propranolol- and furosemide-test in the differential diagnosis of hypertension].
    Kley R; Lommel H
    Med Lab (Stuttg); 1976 Nov; 29(11):247-62. PubMed ID: 995049
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressed plasma renin activity in hypertension.
    Channick BJ; Adlin EV; Marks AD
    Arch Intern Med; 1969 Feb; 123(2):131-40. PubMed ID: 4303266
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relation between prolactin and the renin-angiotensin-aldosterone system].
    Ravaglia G; Cacciari M; Cogliandro SE; Businello M; Ferramosca B; Capelli M; Monti D; Lodi A
    G Clin Med; 1980 Aug; 61(8):611-5. PubMed ID: 7004984
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: Plasma renin activity and aldosterone values in furosemide loading in various diseases].
    Maeda T; Yano T; Idemura H; Idemura R; Odagiri E
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):435. PubMed ID: 4476500
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system.
    Zofková I
    Cor Vasa; 1976; 18(4):304-9. PubMed ID: 1022409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.